Anupam Rasayan India Ltd

Anupam Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Anupam Rasayan India Ltd

₹ 843 0.48%
26 Apr 11:45 a.m.
anupamrasayan.com BSE: 543275 NSE : ANURAS
About

Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.[1]

Key Points

Life Science Specialty Chemicals (~92% revenues)
Under the vertical, the company offers various specialty chemicals across various categories :-
a. Agrochemicals - insecticides, fungicides, herbicides and plant growth regulators.
b. Personal Care - antibacterial and ultraviolet protection intermediates and ingredients.
c. Pharmaceuticals - developing of intermediates and key starting materials for APIs.[1]

Website BSE NSE
  • Market Cap ₹ 9,257 Cr.
  • Current Price ₹ 843
  • High / Low ₹ 1,250 / 782
  • Stock P/E 66.0
  • Book Value ₹ 221
  • Dividend Yield 0.30 %
  • ROCE 10.6 %
  • ROE 8.25 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 34.2% CAGR over last 5 years

Cons

  • Stock is trading at 3.82 times its book value
  • Company has a low return on equity of 8.18% over last 3 years.
  • Company might be capitalizing the interest cost
  • Promoter holding has decreased over last 3 years: -4.14%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
184 272 234 249 266 325 310 314 296 371 288 317 215
131 209 173 185 191 220 213 219 206 279 210 226 151
Operating Profit 53 63 60 63 75 105 97 95 89 92 78 91 64
OPM % 29% 23% 26% 25% 28% 32% 31% 30% 30% 25% 27% 29% 30%
5 3 4 6 5 -8 -13 -5 -4 18 10 4 1
Interest 14 19 7 5 5 14 12 16 14 20 18 20 25
Depreciation 13 13 14 15 16 15 16 16 17 17 17 18 18
Profit before tax 31 33 44 50 60 67 57 58 54 74 54 57 22
Tax % 31% 33% 27% 28% 36% 33% 34% 29% 29% 30% 35% 32% 29%
21 22 32 36 38 45 37 41 39 51 35 39 15
EPS in Rs 2.49 2.22 3.20 3.59 3.79 4.50 3.73 4.11 3.61 4.77 3.24 3.60 1.40
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
107 228 273 288 288 343 502 529 811 1,074 1,284 1,192
86 179 204 208 218 269 408 394 618 770 917 866
Operating Profit 21 49 69 80 70 73 93 134 193 304 367 326
OPM % 19% 22% 25% 28% 24% 21% 19% 25% 24% 28% 29% 27%
0 2 5 8 11 6 19 11 26 7 2 33
Interest 8 22 14 21 21 15 24 45 69 31 62 83
Depreciation 3 5 10 13 15 18 23 29 52 60 66 70
Profit before tax 10 24 50 54 45 48 66 71 99 220 242 205
Tax % 30% 23% 28% 21% 22% 19% 24% 26% 30% 32% 30%
7 18 36 43 35 39 50 53 70 151 169 140
EPS in Rs 7.29 18.45 7.27 8.53 6.96 7.73 10.05 10.60 7.00 15.04 15.69 13.01
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 7% 7% 16%
Compounded Sales Growth
10 Years: %
5 Years: 30%
3 Years: 34%
TTM: -4%
Compounded Profit Growth
10 Years: %
5 Years: 34%
3 Years: 47%
TTM: -14%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 10%
1 Year: -25%
Return on Equity
10 Years: %
5 Years: 9%
3 Years: 8%
Last Year: 8%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 10 10 50 50 50 50 50 50 100 100 107 108
Reserves 23 61 58 97 194 382 432 515 1,473 1,624 2,252 2,313
Preference Capital 0 0 0 0 6 25 25 28 0 0 0
56 117 144 279 312 425 662 818 423 836 822 1,115
20 29 51 55 76 122 170 280 300 325 388 493
Total Liabilities 109 217 303 481 632 978 1,314 1,663 2,295 2,886 3,569 4,028
45 90 145 259 313 379 682 978 1,116 1,203 1,240 1,263
CWIP 1 1 21 64 88 250 183 101 42 43 113 284
Investments 1 0 2 2 2 2 0 0 0 148 158 179
61 126 134 157 230 347 449 583 1,137 1,492 2,057 2,303
Total Assets 109 217 303 481 632 978 1,314 1,663 2,295 2,886 3,569 4,028

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
10 51 68 69 17 -8 42 95 1 -171 244
-8 -38 -88 -168 -93 -247 -261 -178 -192 -412 -478
-1 11 9 100 73 254 209 102 416 384 376
Net Cash Flow 0 24 -10 0 -3 -0 -9 19 224 -199 142

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 45 48 36 28 71 94 88 89 92 95 106
Inventory Days 252 153 158 211 305 411 277 513 528 849 626
Days Payable 81 56 92 94 156 148 105 225 213 223 202
Cash Conversion Cycle 216 144 101 144 220 358 260 378 407 721 530
Working Capital Days 151 120 86 113 152 207 167 184 232 327 302
ROCE % 29% 22% 13% 9% 9% 9% 10% 11% 11%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
65.40% 65.40% 65.40% 65.18% 65.17% 65.16% 60.96% 60.80% 60.77% 60.73% 61.41% 61.26%
6.16% 5.87% 5.73% 5.73% 4.98% 4.59% 8.19% 8.52% 9.79% 10.26% 9.13% 8.07%
2.29% 3.32% 3.75% 3.68% 4.40% 4.40% 6.18% 4.98% 3.74% 1.76% 2.51% 2.56%
26.16% 25.42% 25.12% 25.41% 25.45% 25.84% 24.67% 25.68% 25.71% 27.25% 26.96% 28.10%
No. of Shareholders 77,37171,45460,62965,07165,87071,49273,32666,50761,50461,12960,08957,623

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls